These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 8230453

  • 1. Epstein-Barr virus recombinants from overlapping cosmid fragments.
    Tomkinson B, Robertson E, Yalamanchili R, Longnecker R, Kieff E.
    J Virol; 1993 Dec; 67(12):7298-306. PubMed ID: 8230453
    [Abstract] [Full Text] [Related]

  • 2. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
    Robertson ES, Tomkinson B, Kieff E.
    J Virol; 1994 Mar; 68(3):1449-58. PubMed ID: 8107208
    [Abstract] [Full Text] [Related]

  • 3. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs.
    Robertson E, Kieff E.
    J Virol; 1995 Feb; 69(2):983-93. PubMed ID: 7815566
    [Abstract] [Full Text] [Related]

  • 4. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.
    Tomkinson B, Kieff E.
    J Virol; 1992 Feb; 66(2):780-9. PubMed ID: 1309912
    [Abstract] [Full Text] [Related]

  • 5. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
    Swaminathan S, Tomkinson B, Kieff E.
    Proc Natl Acad Sci U S A; 1991 Feb 15; 88(4):1546-50. PubMed ID: 1847527
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    Wang F, Marchini A, Kieff E.
    J Virol; 1991 Apr 15; 65(4):1701-9. PubMed ID: 1848303
    [Abstract] [Full Text] [Related]

  • 7. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
    Mannick JB, Cohen JI, Birkenbach M, Marchini A, Kieff E.
    J Virol; 1991 Dec 15; 65(12):6826-37. PubMed ID: 1658376
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Cohen JI, Wang F, Mannick J, Kieff E.
    Proc Natl Acad Sci U S A; 1989 Dec 15; 86(23):9558-62. PubMed ID: 2556717
    [Abstract] [Full Text] [Related]

  • 9. Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome.
    Rymo L, Klein G, Ricksten A.
    Proc Natl Acad Sci U S A; 1985 May 15; 82(10):3435-9. PubMed ID: 2987926
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.
    Marchini A, Longnecker R, Kieff E.
    J Virol; 1992 Aug 15; 66(8):4972-81. PubMed ID: 1321281
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
    Cohen JI, Picchio GR, Mosier DE.
    J Virol; 1992 Dec 15; 66(12):7555-9. PubMed ID: 1331538
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
    Tomkinson B, Robertson E, Kieff E.
    J Virol; 1993 Apr 15; 67(4):2014-25. PubMed ID: 8445720
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.
    Cho MS, Gissmann L, Hayward SD.
    Virology; 1984 Aug 15; 137(1):9-19. PubMed ID: 6089423
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    Cohen JI, Wang F, Kieff E.
    J Virol; 1991 May 15; 65(5):2545-54. PubMed ID: 1850028
    [Abstract] [Full Text] [Related]

  • 16. Efficient expression of an Epstein-Barr nuclear antigen in Drosophila cells transfected with Epstein-Barr virus DNA.
    Allday MJ, Sinclair JH, MacGillivray AJ, Sang JH.
    EMBO J; 1985 Nov 15; 4(11):2955-9. PubMed ID: 2998769
    [Abstract] [Full Text] [Related]

  • 17. trans-acting requirements for replication of Epstein-Barr virus ori-Lyt.
    Fixman ED, Hayward GS, Hayward SD.
    J Virol; 1992 Aug 15; 66(8):5030-9. PubMed ID: 1321285
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E.
    J Virol; 1990 May 15; 64(5):2309-18. PubMed ID: 2157887
    [Abstract] [Full Text] [Related]

  • 19. Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA.
    Jenson HB, Rabson MS, Miller G.
    J Virol; 1986 May 15; 58(2):475-86. PubMed ID: 3009861
    [Abstract] [Full Text] [Related]

  • 20. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.
    Rooney CM, Brimmell M, Buschle M, Allan G, Farrell PJ, Kolman JL.
    J Virol; 1992 Jan 15; 66(1):496-504. PubMed ID: 1309259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.